Prof. Olivier Hermine, hematologist at the Necker-enfants malades Hospital (AP-HP), demonstrates the interest of personalized medicine in hematology. Indeed, a good knowledge of medical and fundamental biology makes it possible to understand the origin of the tumor and to define a better treatment strategy for the patient.
Acute Myeloid Leukemia: identification of a new targeted therapy approach
April 14, 2022
Acute myeloid leukemia (AML) is a hematologic malignancy that develops from hematopoietic stem
